{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:36:27Z","timestamp":1793799387577,"version":"4.6.1"},"reference-count":99,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2020,8,26]]},"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:p>Cirrhotic portal hypertension is characterised by development of the decompensating events of ascites, encephalopathy, portal hypertensive bleeding and hepatorenal syndrome, which arise in a setting of cirrhosis-associated immune dysfunction (CAID) and define morbidity and prognosis. CAID describes the dichotomous observations that systemic immune cells are primed and display an inflammatory phenotype, while failing to mount robust responses to pathogen challenge. Bacterial infections including spontaneous bacterial peritonitis are common complications of advanced chronic liver disease and can precipitate variceal haemorrhage, hepatorenal syndrome and acute-on-chronic liver failure; they frequently arise from gut-derived organisms and are closely linked with dysbiosis of the commensal intestinal microbiota in advanced chronic liver disease.<\/jats:p>\n                  <jats:p>Here, we review the links between cirrhotic dysbiosis, intestinal barrier dysfunction and deficits of host-microbiome compartmentalisation and mucosal immune homoeostasis that occur in settings of advanced chronic liver disease. We discuss established and emerging therapeutic strategies targeted at restoring intestinal eubiosis, augmenting gut barrier function and ameliorating the mucosal and systemic immune deficits that characterise and define the course of decompensated cirrhosis.<\/jats:p>","DOI":"10.1136\/gutjnl-2020-320786","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T17:20:37Z","timestamp":1602782437000},"page":"982-994","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":146,"title":["Targeting the gut-liver-immune axis to treat cirrhosis"],"prefix":"10.1136","volume":"70","clinical-trial-number":[{"clinical-trial-number":"nct03780673","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03892070","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03202498","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02689245","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9290-3044","authenticated-orcid":false,"given":"Thomas Henry","family":"Tranah","sequence":"first","affiliation":[{"name":"Institute of Liver Studies, Department of Inflammation Biology, School of Immunology and Microbial Sciences, FoLSM, King's College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8222-4555","authenticated-orcid":false,"given":"Lindsey A","family":"Edwards","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, Department of Inflammation Biology, School of Immunology and Microbial Sciences, FoLSM, King's College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Schnabl","sequence":"additional","affiliation":[{"name":"Medicine, University of California San Diego, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6133-4619","authenticated-orcid":false,"given":"Debbie Lindsay","family":"Shawcross","sequence":"additional","affiliation":[{"name":"Institute of Liver Studies, Department of Inflammation Biology, School of Immunology and Microbial Sciences, FoLSM, King's College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"2025121304023805000_70.5.982.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2011.02716.x"},{"key":"2025121304023805000_70.5.982.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.10.013"},{"key":"2025121304023805000_70.5.982.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.200"},{"key":"2025121304023805000_70.5.982.4","doi-asserted-by":"publisher","DOI":"10.1038\/nature08821"},{"key":"2025121304023805000_70.5.982.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.1104816"},{"key":"2025121304023805000_70.5.982.6","first-page":"G1415","article-title":"Short-Chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat","volume":"275","author":"Cherbut","year":"1998","journal-title":"Am J Physiol"},{"key":"2025121304023805000_70.5.982.7","doi-asserted-by":"publisher","DOI":"10.3945\/jn.109.104638"},{"key":"2025121304023805000_70.5.982.8","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2015.1134082"},{"key":"2025121304023805000_70.5.982.9","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2014.44"},{"key":"2025121304023805000_70.5.982.10","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31827fec6d"},{"key":"2025121304023805000_70.5.982.11","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2008.289"},{"key":"2025121304023805000_70.5.982.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1785-z"},{"key":"2025121304023805000_70.5.982.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.01.003"},{"key":"2025121304023805000_70.5.982.14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fcimb.2017.00254","article-title":"Type VI secretion effectors: methodologies and biology","volume":"7","author":"Lien","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"2025121304023805000_70.5.982.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2016.03.002"},{"key":"2025121304023805000_70.5.982.16","doi-asserted-by":"crossref","first-page":"ofx144","DOI":"10.1093\/ofid\/ofx144","article-title":"The intestinal microbiome in infectious diseases: the clinical relevance of a rapidly emerging field","volume":"4","author":"Harris","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2025121304023805000_70.5.982.17","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.1501.01039"},{"key":"2025121304023805000_70.5.982.18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3390\/pathogens3030769","article-title":"Early development of the gut microbiota and immune health","volume":"3","author":"Francino","year":"2014","journal-title":"Pathogens"},{"key":"2025121304023805000_70.5.982.19","doi-asserted-by":"publisher","DOI":"10.1126\/science.1241165"},{"key":"2025121304023805000_70.5.982.20","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.36","article-title":"Microbiota in T-cell homeostasis and inflammatory diseases","volume":"49","author":"Lee","year":"2017","journal-title":"Exp Mol Med"},{"key":"2025121304023805000_70.5.982.21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26319"},{"key":"2025121304023805000_70.5.982.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.04.001"},{"key":"2025121304023805000_70.5.982.23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26093"},{"key":"2025121304023805000_70.5.982.24","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-164921"},{"key":"2025121304023805000_70.5.982.25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303816"},{"key":"2025121304023805000_70.5.982.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0061-3"},{"key":"2025121304023805000_70.5.982.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.04.019"},{"key":"2025121304023805000_70.5.982.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2016.02.004"},{"key":"2025121304023805000_70.5.982.29","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.3892\/mmr.2014.2126","article-title":"Effects of alcohol on intestinal epithelial barrier permeability and expression of tight junction-associated proteins","volume":"9","author":"Wang","year":"2014","journal-title":"Mol Med Rep"},{"key":"2025121304023805000_70.5.982.30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota","volume":"16","author":"Bajaj","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025121304023805000_70.5.982.31","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90027-6"},{"key":"2025121304023805000_70.5.982.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.12.019"},{"key":"2025121304023805000_70.5.982.33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI90562"},{"key":"2025121304023805000_70.5.982.34","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31459","article-title":"Intestinal virome in patients with alcoholic hepatitis","author":"Jiang","year":"2020","journal-title":"Hepatology"},{"key":"2025121304023805000_70.5.982.35","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/apt.14949","article-title":"Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis","volume":"48","author":"Ciocan","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121304023805000_70.5.982.36","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310585"},{"key":"2025121304023805000_70.5.982.37","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep4.1331","article-title":"Role of the Gut-Liver axis in liver inflammation, fibrosis, and cancer: a special focus on the gut microbiota relationship","volume":"3","author":"Ohtani","year":"2019","journal-title":"Hepatol Commun"},{"key":"2025121304023805000_70.5.982.38","doi-asserted-by":"publisher","DOI":"10.1038\/nm1663"},{"key":"2025121304023805000_70.5.982.39","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3892\/mmr.2014.2995","article-title":"Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model","volume":"11","author":"Douhara","year":"2015","journal-title":"Mol Med Rep"},{"key":"2025121304023805000_70.5.982.40","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/hep.29646","article-title":"Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis","volume":"67","author":"Garc\u00eda-Lezana","year":"2018","journal-title":"Hepatology"},{"key":"2025121304023805000_70.5.982.41","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.72"},{"key":"2025121304023805000_70.5.982.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.02.007"},{"key":"2025121304023805000_70.5.982.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05791.x"},{"key":"2025121304023805000_70.5.982.44","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24423"},{"key":"2025121304023805000_70.5.982.45","doi-asserted-by":"publisher","DOI":"10.1038\/nature13568"},{"key":"2025121304023805000_70.5.982.46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00042737-200204000-00006","article-title":"Ultrastructural characteristics of distal duodenum mucosa in patients with cirrhosis","volume":"14","author":"Such","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025121304023805000_70.5.982.47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2011.02609.x"},{"key":"2025121304023805000_70.5.982.48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24789"},{"key":"2025121304023805000_70.5.982.49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027030"},{"key":"2025121304023805000_70.5.982.50","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf4822"},{"key":"2025121304023805000_70.5.982.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.08.006"},{"key":"2025121304023805000_70.5.982.52","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.30349","article-title":"Intestinal immune dysregulation driven by dysbiosis promotes barrier disruption and bacterial translocation in rats with cirrhosis","volume":"70","author":"Mu\u00f1oz","year":"2019","journal-title":"Hepatology"},{"key":"2025121304023805000_70.5.982.53","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jhep.2020.03.019","article-title":"Paneth cells promote angiogenesis and regulate portal hypertension in response to microbial signals","volume":"73","author":"Hassan","year":"2020","journal-title":"J Hepatol"},{"key":"2025121304023805000_70.5.982.54","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0135"},{"key":"2025121304023805000_70.5.982.55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26509-y","article-title":"Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy","volume":"8","author":"Iebba","year":"2018","journal-title":"Sci Rep"},{"key":"2025121304023805000_70.5.982.56","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316227"},{"key":"2025121304023805000_70.5.982.57","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.06.019"},{"key":"2025121304023805000_70.5.982.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.08.010"},{"key":"2025121304023805000_70.5.982.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.06.026"},{"key":"2025121304023805000_70.5.982.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.027"},{"key":"2025121304023805000_70.5.982.61","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300779"},{"key":"2025121304023805000_70.5.982.62","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1111\/liv.13172","article-title":"Selective intestinal decontamination with norfloxacin enhances a regulatory T cell-mediated inflammatory control mechanism in cirrhosis","volume":"36","author":"Juanola","year":"2016","journal-title":"Liver Int"},{"key":"2025121304023805000_70.5.982.63","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907893"},{"key":"2025121304023805000_70.5.982.64","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/apt.15326","article-title":"Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all-cause admissions in patients on the liver transplant waiting list","volume":"50","author":"Salehi","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121304023805000_70.5.982.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.027"},{"key":"2025121304023805000_70.5.982.66","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jhep.2018.07.019","article-title":"Statins: old drugs as new therapy for liver diseases?","volume":"70","author":"Pose","year":"2019","journal-title":"J Hepatol"},{"key":"2025121304023805000_70.5.982.67","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.01.004"},{"key":"2025121304023805000_70.5.982.68","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41575-019-0173-3","article-title":"Probiotics and prebiotics in intestinal health and disease: from biology to the clinic","volume":"16","author":"Sanders","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025121304023805000_70.5.982.69","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.232918"},{"key":"2025121304023805000_70.5.982.70","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20961"},{"key":"2025121304023805000_70.5.982.71","article-title":"Probiotics for people with hepatic encephalopathy","volume":"2","author":"Dalal","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121304023805000_70.5.982.72","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41575-019-0173-3","article-title":"Probiotics and prebiotics in intestinal health and disease: from biology to the clinic","volume":"16","author":"Sanders","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025121304023805000_70.5.982.73","doi-asserted-by":"publisher","DOI":"10.3945\/jn.114.209486"},{"key":"2025121304023805000_70.5.982.74","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/00365521.1997.11720717","article-title":"Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection","volume":"222","author":"Salminen","year":"1997","journal-title":"Scand J Gastroenterol Suppl"},{"key":"2025121304023805000_70.5.982.75","doi-asserted-by":"crossref","first-page":"11595","DOI":"10.1096\/fj.201901327R","article-title":"Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis","volume":"33","author":"Juanola","year":"2019","journal-title":"Faseb J"},{"key":"2025121304023805000_70.5.982.76","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1742-x"},{"key":"2025121304023805000_70.5.982.77","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/j.gastro.2018.08.022","article-title":"FXR-Dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid","volume":"155","author":"Friedman","year":"2018","journal-title":"Gastroenterology"},{"key":"2025121304023805000_70.5.982.78","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33041-7"},{"key":"2025121304023805000_70.5.982.79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.017"},{"key":"2025121304023805000_70.5.982.80","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/hep4.1108","article-title":"Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice","volume":"1","author":"Zhou","year":"2017","journal-title":"Hepatol Commun"},{"key":"2025121304023805000_70.5.982.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.12.011"},{"key":"2025121304023805000_70.5.982.82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2009.02038.x"},{"key":"2025121304023805000_70.5.982.83","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26338"},{"key":"2025121304023805000_70.5.982.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.08.006"},{"key":"2025121304023805000_70.5.982.85","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30840-7"},{"key":"2025121304023805000_70.5.982.86","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jhep.2020.01.011","article-title":"Toll-Like receptor 4 is a therapeutic target for prevention and treatment of liver failure","volume":"73","author":"Engelmann","year":"2020","journal-title":"J Hepatol"},{"key":"2025121304023805000_70.5.982.87","doi-asserted-by":"crossref","first-page":"9922","DOI":"10.18632\/oncotarget.14266","article-title":"Antagonism of interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10\/STAT3-suppressed autophagy in hepatocytes","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"2025121304023805000_70.5.982.88","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25744"},{"key":"2025121304023805000_70.5.982.89","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2017.10.010"},{"key":"2025121304023805000_70.5.982.90","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000917"},{"key":"2025121304023805000_70.5.982.91","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/hep.28121","article-title":"Fecal microbiota transplantation in the management of hepatic encephalopathy","volume":"63","author":"Kao","year":"2016","journal-title":"Hepatology"},{"key":"2025121304023805000_70.5.982.92","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"key":"2025121304023805000_70.5.982.93","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1053\/j.gastro.2019.01.033","article-title":"Long-Term outcomes of fecal microbiota transplantation in patients with cirrhosis","volume":"156","author":"Bajaj","year":"2019","journal-title":"Gastroenterology"},{"key":"2025121304023805000_70.5.982.94","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"key":"2025121304023805000_70.5.982.95","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in Steroid-Ineligible severe alcoholic hepatitis: a pilot study","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025121304023805000_70.5.982.96","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12664-018-0859-4","article-title":"Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis","volume":"37","author":"Philips","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"2025121304023805000_70.5.982.97","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.14309\/ajg.0000000000000115","article-title":"Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial","volume":"114","author":"Allegretti","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"2025121304023805000_70.5.982.98","doi-asserted-by":"crossref","DOI":"10.1016\/S0618-8278(19)30181-1","article-title":"PS-163-Faecal microbiota transplantation with tenofovir is superior to tenofovir alone in improving clinical outcomes in acute-on-chronic liver failure due to hepatitis B: an open label randomized controlled trial (NCT02689245)","volume":"70","author":"Ahmad","year":"2019","journal-title":"J Hepatol"},{"key":"2025121304023805000_70.5.982.99","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/hep.29008","article-title":"Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy","volume":"65","author":"Ren","year":"2017","journal-title":"Hepatology"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2020-320786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T12:02:48Z","timestamp":1765627368000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2020-320786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":99,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,4,7]]},"published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10.1136\/gutjnl-2020-320786"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2020-320786","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]}}}